A 26-year-old man suffered from chronic alcoholism and had multiple body tatoos and perforations. Illness began 5 days prior to hospital admission with hematemesis and recurrent melena and he presented with hemodynamic decompensation and shock. The patient stated that he did not take nonsteroidal anti-inflammatory agents or other drugs and he had no signs of peptic acid disease. Physical examination revealed blood pressure of 80/40 mmHg, heart rate 130 min, generalized pallor, diaphoresis, and no hepatopathy stigmata. Laboratory work-up reported: hemoglobin 3.62 mg/dl, MCV 93.2 3 , MCH 34.2 g/dl, leukocytes 7,470 mm 3 , and platelets 151,000 mm 3 . Blood chemistry showed normal serum electrolytes and liver function tests; AcHC, HBsAg, and HIV were negative. Liver ultrasound was normal. Endoscopy revealed Dieulafoy's lesion in the gastric fundus at 4 cm from the cardia with active bleeding (figs. 1 and 2). Sclerotherapy with polidocanol at 1% was performed and bleeding was controlled ( fig. 3) . The patient remained asymptomatic and was released one week later with Hb of 9.2 mg/dl.
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Dieulafoy's lesion
A 26-year-old man suffered from chronic alcoholism and had multiple body tatoos and perforations. Illness began 5 days prior to hospital admission with hematemesis and recurrent melena and he presented with hemodynamic decompensation and shock. The patient stated that he did not take nonsteroidal anti-inflammatory agents or other drugs and he had no signs of peptic acid disease. Physical examination revealed blood pressure of 80/40 mmHg, heart rate 130 min, generalized pallor, diaphoresis, and no hepatopathy stigmata. Laboratory work-up reported: hemoglobin 3.62 mg/dl, MCV 93.2 3 , MCH 34.2 g/dl, leukocytes 7,470 mm 3 , and platelets 151,000 mm 3 . Blood chemistry showed normal serum electrolytes and liver function tests; AcHC, HBsAg, and HIV were negative. Liver ultrasound was normal. Endoscopy revealed Dieulafoy's lesion in the gastric fundus at 4 cm from the cardia with active bleeding (figs. 1 and 2). Sclerotherapy with polidocanol at 1% was performed and bleeding was controlled ( fig. 3) . The patient remained asymptomatic and was released one week later with Hb of 9.2 mg/dl. 
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